ImStar Therapeutics

About:

ImStar Therapeutics is a biotech company that develops treatments for patients with amyotrophic lateral sclerosis.

Twitter/X: imstartx

Top Investors: BDC Venture Capital, CQDM, Brain Canada, E-Fund, ALS Society of Canada

Description:

ImStar Therapeutics is a biotech company that develops treatments for patients with amyotrophic lateral sclerosis. Its product pipeline is comprised of IMS-088, a small-molecule compound designed to address immune system activation pathway involved in neurodegeneration; and TDP-43 Associated NF-kB Activation Inhibitors.ImStar Therapeutics was founded in 2012 and is based in Vancouver, Canada.

Total Funding Amount:

$4.82M

Headquarters Location:

Vancouver, British Columbia, Canada

Founded Date:

2012-01-01

Contact Email:

info(AT)imstartx.com

Founders:

Daniel Wattier, Jean Pierre Julien

Number of Employees:

11-50

Last Funding Date:

2017-02-09

IPO Status:

Private

Industries: